ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Inventiva Sa

Inventiva Sa (0RNK)

7.62
0.00
(0.00%)
Closed 21 June 1:30AM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
7.62
Bid
0.00
Offer
0.00
Volume
0.00
0.00 Day's Range 0.00
7.62 52 Week Range 7.62
Market Cap
Previous Close
7.62
Open
-
Last Trade
(O)
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
529
Shares Outstanding
52,116,000
Dividend Yield
-
PE Ratio
-1.28
Earnings Per Share (EPS)
-2.12
Revenue
23.16M
Net Profit
-110.43M

About Inventiva Sa

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Headquarters
Daix, Fra
Founded
1970
Inventiva Sa is listed in the Biological Pds,ex Diagnstics sector of the London Stock Exchange with ticker 0RNK. The last closing price for Inventiva was 7.62 €. Over the last year, Inventiva shares have traded in a share price range of 7.62 € to 7.62 €.

Inventiva currently has 52,116,000 shares in issue. The market capitalisation of Inventiva is 141.76 € million. Inventiva has a price to earnings ratio (PE ratio) of -1.28.

0RNK Latest News

Statement of total voting rights and shares forming the company’s share capital as of May 13, 2024

Statement of total voting rights and shares forming the company’s share capital as of May 13, 2024 Article R. 22-10-23 of the French Commercial Code Market : Euronext ParisISIN code / Mnemo :...

Inventiva announces two scientific presentations at the EASL International Liver Congress™ 2024

Inventiva announces two scientific presentations at the EASL International Liver Congress™ 2024 The first abstract demonstrates that the improvements of MACK-3, a diagnostic test for...

Inventiva publie ses informations financières du 1 ͤ ͬ trimestre 2024¹ et fait un point sur ses activités

Inventiva publie ses informations financières du 1 ͤ ͬ trimestre 2024¹ et fait un point sur ses activités Au 31 mars 2024, trésorerie et équivalents de trésorerie à 11,0 millions d’euros...

Inventiva annonce la recommandation positive du quatrième DMC de l’étude clinique NATiV3 Phase III avec lanifibranor dans la MASH/NASH

Inventiva annonce la recommandation positive du quatrième DMC de l’étude clinique NATiV3 Phase III avec lanifibranor dans la MASH/NASH Le Data Monitoring Committee recommande sur la base...

Inventiva annonce la publication dans Nature Communications de résultats complémentaires de l’étude clinique de Phase II NATIVE démontrant l’amélioration de marqueurs de santé cardiométabolique chez les patients atteints de MASH/NASH traité

Inventiva annonce la publication dans Nature Communications de résultats complémentaires de l’étude clinique de Phase II NATIVE démontrant l’amélioration de marqueurs de santé cardiométabolique...

Inventiva announces filing of its 2023 Universal Registration Document and 2023 Annual Report on Form 20-F

Inventiva announces filing of its 2023 Universal Registration Document and 2023 Annual Report on Form 20-F Daix (France), Long Island City (New York, United States), April 3, 2024 – Inventiva...

Inventiva announces the nomination of Andre Turenne as Director

Inventiva announces the nomination of Andre Turenne as Director Daix (France), Long Island City (New York, United States), March 28, 2024 – Inventiva (Euronext Paris and Nasdaq: IVA) (the...

Inventiva reports its 2023 full-year results

Inventiva reports its 2023 full-year results Revenues at €17.5 million for the full year of 2023 up 43.4% compared to €12.2 million for 2022 Cash and cash equivalents at €26.9 million...

Inventiva announces positive results from the Phase II, LEGEND, Proof-of-Concept study combining lanifibranor with empagliflozin in patients with MASH/NASH and T2D

Inventiva announces positive results from the Phase II, LEGEND, Proof-of-Concept study combining lanifibranor with empagliflozin in patients with MASH/NASH and T2D LEGEND achieved its primary...

Inventiva annonce les résultats positifs de l’essai clinique de Phase II, preuve de concept, LEGEND, combinant lanifibranor et empagliflozine chez des patients atteints de MASH/NASH et de diabète de type 2

Inventiva annonce les résultats positifs de l’essai clinique de Phase II, preuve de concept, LEGEND, combinant lanifibranor et empagliflozine chez des patients atteints de MASH/NASH et de diabète...

Period †ChangeChange %OpenHighLowAvg. Daily VolVWAP
1007.627.627.6227.62DE
4007.627.627.6247.62DE
12007.627.627.625297.62DE
26007.627.627.6212317.62DE
52007.627.627.6225947.62DE
156007.627.627.6228017.62DE
260007.627.627.6247037.62DE

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
1ADAdAlta Limited
AUD 0.026
(0.00%)
0
14DO1414 Degrees Limited
AUD 0.008
(0.00%)
0
14DN1414 Degrees Limited
AUD 0.00
(0.00%)
0
14D1414 Degrees Limited
AUD 0.066
(0.00%)
0
13S13 Seeds Limited
 0.00
(0.00%)
0
1ADAdAlta Limited
AUD 0.026
(0.00%)
0
14DO1414 Degrees Limited
AUD 0.008
(0.00%)
0
14DN1414 Degrees Limited
AUD 0.00
(0.00%)
0
14D1414 Degrees Limited
AUD 0.066
(0.00%)
0
13S13 Seeds Limited
 0.00
(0.00%)
0
TAHTabcorp Holdings Limited
AUD 1.31
(0.00%)
13.58M
SGRStar Entertainment Group Limited
AUD 2.94
(0.00%)
6.49M
NABNational Australia Bank Limited
AUD 37.01
(0.00%)
5.04M
MGRMirvac Group
AUD 2.41
(0.00%)
4.34M
AWCAlumina Limited
AUD 3.01
(0.00%)
3.73M

Discussion

View Full Feed
mrwrn2010 mrwrn2010 20 seconds ago
Snagged a few more shares today, leggo
ELTP
Wavefan11 Wavefan11 30 seconds ago
Hola Pura Vida. Thanks for your help with understanding all of this. It seems to be quite a rabbit hole. So sorry about your friend.
AVRW
Kool Aid Man Kool Aid Man 1 minute ago
Which statistic..which players?
NHMD
Large Green Large Green 1 minute ago
Newflow let everyone NOTE WMMSC is still in business and doing business as recent as 2/8/2024

Dated: February 8, 2024
WASHINGTON MUTUAL MORTGAGE

SECURITIES CORP.

(Securitizer)


Newflow, some less fortunate and late timel
COOP
couldbebetter couldbebetter 2 minutes ago
Kiwi, You may be right regarding the conservation of cash,
especially if it is earning a high interest rate. However, our
information is not as good as what management has, so I
would trust their judgement. China remains a wildcard as
to what their sales will be like e
AMRN
louieforpar louieforpar 2 minutes ago
Quite sure this poster is in the camp of these idiots.


https://www.google.com/url?q=https://www.rawstory.com/amp/trump-flat-earth-2668520151&sa=U&sqi=2&ved=2ahUKEwiPt7mwo-uGAxWklYkEHQ7WCn8QFnoECA4QAQ&usg=AOvVaw3wYTWPUGZrTdxWMWVujJGu
DJT
Real McCoy Real McCoy 2 minutes ago
As soon as the remaining “holdouts” do the same, I’m out.
stockstobuy stockstobuy 2 minutes ago
Where did you get that 7mil cos i only know 6Mil? Either way that's still a lot of sign ups that will convert into revenue streams. I hope to see at least 20 cents by EOY.
NSAV
lvhd lvhd 3 minutes ago
He does the same on SPY’s board!
NVDA
waterchaser waterchaser 4 minutes ago
Spot on… thank you.
DJT
HGilS HGilS 4 minutes ago
I think they will need still security to transport the finish goods to the new facility. Unless they dig a tunnel or something.
ELTP
Smattchew Smattchew 5 minutes ago
acknowledging that it is dead, $bioaq...
don't tease.
BIOAQ
DesertDrifter DesertDrifter 5 minutes ago
Well, the organized crime framework is so obvious that they are trying to hide in plain sight. And succeeding, to a scary degree.

I nearly had another coronary when one of my daughters said she thinks that trump did more for the working poor than biden. She says inflation is destro
rosemountbomber rosemountbomber 5 minutes ago
Is the net loss a result of:

1) costs related to EU rollouts?
2) costs related to US operations?
3) selling V for below cost? (specifically in the US since they are making deals with insurers)

I am sure it is a combo of 1 and 2 (although 2 should be down t
AMRN
Spike5 Spike5 5 minutes ago
Sorry I mean you are correct … I have turned spell check off on my phone more times than I can count
GERN
Waverunners Waverunners 6 minutes ago
Hilarious, after I quote you stating “I told you so,” you go on to say I’m always saying I’m right.
Of course you ended up being wrong, but the point remains the same.
Imagine how you’ll react if you are ever right about something.
I guess we may never find out.
UEEC
subtlerise subtlerise 6 minutes ago
TKMO $ chart 14 day RSI at 65.47 which the highest since Nov 12 2023 and volume the highest period.Broke through the 100 DMA which was at .0007....200 dma @.0012......lookin juicy!
TKMO
Menace212 Menace212 6 minutes ago
Facts every dip has been bought up real quick even when we hit 0022 got took to 0026 in less than 5 minutes flippers will take advantage of this.

But real traders pay no mind based off company
RSPI
Lime Time Lime Time 6 minutes ago
Bottom is in. Can't wait for this to run hard to pennies 🚀
CIVX
MA52TA MA52TA 6 minutes ago
If it were up to you, you would have already liquidated the company. Fortunately, I think that AMARIN management has other plans. Plans that are neither mine nor yours.
AMRN
louieforpar louieforpar 7 minutes ago
How about a show of hands how many of you Trump supporting posters here went to this event?


Here’s yet another for the can’t-think for themselves-conspiracy idiots.Really?You honestly thought the Kennedys were going to show up.Did Alex Jones show up?

How many
DJT
xxxx xxxx 7 minutes ago
Op worthlss of c
SHIBUSD
RobotDroid RobotDroid 7 minutes ago
Haha like I care if some anonymous message board poster responds to me like you just did. Too funny.
NWBO

Your Recent History

Delayed Upgrade Clock